What steps are necessary to optimize the patient's journey across the Slovak Health Service? How can we be inspired abroad and what are the ministry's plans? What should the optimization of the patient journey look like in mental health, in cardiovascular diseases or in oncology?

Slovakia is preparing for new investments from EU sources. What opportunities does this bring for our healthcare industry? What are the planned investments from the Slovakia Program or the Recovery Plan? And how to set them up so that they bring the greatest possible added value?

In an era where technological advances are rapidly changing the healthcare landscape, ensuring the security of sensitive patient data is more important than ever. As healthcare organizations increasingly embrace digital innovation, they face unprecedented challenges in protecting patient information from evolving cyber threats. Explore new trends that will shape the future of healthcare data security.

What are the real needs of Slovak hospitals? Is there a technology needs map? Are we deploying digital innovations at a sufficient pace and to the necessary extent? Can we use European funds to cover these needs?

How do we need to change public procurement in order to increase the effectiveness of the Slovak healthcare system? Is joint shopping the solution? How can we buy modern technologies for hospitals? Can we buy innovations?

Insufficient network of clinics, lack of specialists, high number of doctors of retirement age, significant underfunding. These are just some of the symptoms of the ever-deteriorating state of the ambulatory sector. What steps are necessary for system renewal and support of the ambulatory sector in Slovakia? What are the planned steps of the Ministry of Health in supporting the ambulatory sector?

Why do we need an innovation fund in Slovakia and how can clinical trials increase the availability of innovative treatment? What steps are necessary for us in Slovakia to be able to treat patients with innovative forms of treatment and modern medicines?

How clinical trials can accelerate innovation in medicine, improve the quality of healthcare and the availability of innovative treatments for patients, while saving public money.

What challenges and changes await us in the near future in the ambulatory sector? How can we stabilize the personnel situation in hospitals? Is the state implementing sufficiently effective measures to motivate people to prevent? Is one of the goals of the new government to increase awareness of the importance of prevention for the health of the population? Can the state respond effectively to the growing investment debt in Slovak hospitals? What is the main problem of financing hospitals and how can the state pay off the debts of hospitals? Is the DRG system an objective and transparent mechanism for improving the management and financing of provided institutional health care?